LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bear
Stearns Healthcare Conference in New York City on Tuesday, September 11, 2007.
The Quest Diagnostics presentation is scheduled to begin at 9:30 a.m. Eastern
Time.
During the conference, the company will reiterate its 2007 guidance for
revenues of between $6.6 billion and $6.7 billion, operating income of
approximately 16% of revenues, and earnings per diluted share from continuing
operations of between $2.80 and $2.95. These estimates exclude $0.04 per
share in total first quarter charges associated with workforce reductions and
the expense of in-process research and development, and are before charges
related to potential additional restructuring activities.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://cc.talkpoint.com/BEAR002/091007a_sc/?entity=quest and to the public on
http://www.questdiagnostics.com. In addition, the archived webcast will be
available four hours after conclusion of the live event and will remain
available until October 11, 2007.
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2006 Form 10-K and subsequent SEC filings.
SOURCE Quest Diagnostics Incorporated
-0- 09/10/2007
/CONTACT: Investors: Laure Park, +1-201-393-5030; Media: Gary Samuels,
+1-201-393-5700, both of Quest Diagnostics Incorporated/
/Web site: http://www.questdiagnostics.com
http://cc.talkpoint.com/BEAR002/091007a_sc/?entity=quest/
(DGX)
CO: Quest Diagnostics Incorporated; Bear Stearns Healthcare Conference
ST: New Jersey
IN: MTC HEA
SU: CCA TDS
VD-AP
-- NYM001 --
9952 09/10/2007 08:00 EDT http://www.prnewswire.com